Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI)

CAPS Rating: 5 out of 5

A specialty pharmaceutical and medical device company that discovers, develops and markets innovative technologies and medical products for local diseases, and for other complications.

Recs

0
Player Avatar fburks (< 20) Submitted: 9/3/2008 9:18:13 AM : Outperform Start Price: $1.62 ANPI Score: -93.62

First of all I have a very small position in this company. I based this position of my professional use of one of its products: Quills self retaining sutures. This is a great product that will probably grow in its use. I know this company has struggled with debt and reduced stent income, but I would still consider it a buy.

Featured Broker Partners


Advertisement